Puma Biotechnology
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Post-IPO Equity - Puma Biotechnology - 2022-03-10 - Crunchbase Funding Round Profile
Articles about Puma Biotechnology
Puma Biotechnology reports interim SUMMIT results for neratinib | Drug Discovery News
Puma Biotechnology
Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference
Puma Biotechnology Inc (PBYI) Stock: What Does the Chart Say Tuesday?
Puma Biotechnology (PBYI) Price Target Increased by 5.26% to 5.10
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Puma Biotechnology (NASDAQ:PBYI) Stock Rating Upgraded by StockNews.com - MarketBeat
Puma Biotechnology Inc (PBYI) Stock News | Stock Titan
Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today | The Motley Fool
Puma Biotechnology falls more than 20%
PumaBiotech (@pumabiotech) / X
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Third Quarter 2022 Financial Results | Business Wire
Puma Biotechnology Surging
Puma Biotech (PBYI) Stock Jumps 10.0%: Will It Continue to Soar?
Puma Biotech gets EU panel nod for breast cancer drug, Health News, ET HealthWorld
Puma Biotechnology Receives Buy Rating and Shows Potential for Significant Growth - Best Stocks
Puma Biotech punts near $300 million on Takeda discard
Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference
Puma Biotech granted Orphan Drug status for lung cancer candida | Seeking Alpha
